Chemical Formula: C18H29NO2

Chemical Formula C18H29NO2

Found 44 metabolite its formula value is C18H29NO2

Penbutolol

(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol

C18H29NO2 (291.2198174)


Penbutolol is only found in individuals that have used or taken this drug. It is a medication in the class of beta blockers, used in the treatment of high blood pressure. [Wikipedia]Penbutolol competes with adrenergic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle and beta(2)-receptors in the bronchial and vascular smooth muscle. Beta(1)-receptor blockade results in a decrease in resting and exercise heart rate and cardiac output, a decrease in both systolic and diastolic blood pressure, and, possibly, a reduction in reflex orthostatic hypotension. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Exaprolol

1-(2-cyclohexylphenoxy)-3-[(propan-2-yl)amino]propan-2-ol

C18H29NO2 (291.2198174)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Ketocaine

1-(2-(2-(Bis(1-methylethyl)amino)ethoxy)phenyl)-1-butanone

C18H29NO2 (291.2198174)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Acetyldihydrolycopodine

Acetyldihydrolycopodine

C18H29NO2 (291.2198174)


   
   

(2E,4E,8Z,11Z)-2-hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide|(2E,4E,8Z,11Z)-N-(2-hydroxy-2-methylpropyl)-2,4,8,11-tetradecatetraenamide|bungeanool|N-(2-methyl-2-hydroxypropyl)tetradeca-(2E,4E,8Z,11Z)-tetraeneamide

(2E,4E,8Z,11Z)-2-hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide|(2E,4E,8Z,11Z)-N-(2-hydroxy-2-methylpropyl)-2,4,8,11-tetradecatetraenamide|bungeanool|N-(2-methyl-2-hydroxypropyl)tetradeca-(2E,4E,8Z,11Z)-tetraeneamide

C18H29NO2 (291.2198174)


   

(2E,4E,8Z,11Z)-2-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide

(2E,4E,8Z,11Z)-2-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide

C18H29NO2 (291.2198174)


   

5-Hydroxy-2-methyl-6-(11-oxododecyl)-pyridine|5-hydroxy-2-methyl-6-(11-oxododecyl)pyridine

5-Hydroxy-2-methyl-6-(11-oxododecyl)-pyridine|5-hydroxy-2-methyl-6-(11-oxododecyl)pyridine

C18H29NO2 (291.2198174)


   
   

(2E,4E,8Z,10E)-12-hydroxy-N-(2-methylpropyl)tetradeca-2,4,8,10-tetraenamide|Lanyuamide VI

(2E,4E,8Z,10E)-12-hydroxy-N-(2-methylpropyl)tetradeca-2,4,8,10-tetraenamide|Lanyuamide VI

C18H29NO2 (291.2198174)


   
   

(2E,4E,8Z)-12-keto-N-isobutyl-2,4,8-tetradecatrienamide|Lanyuamide II

(2E,4E,8Z)-12-keto-N-isobutyl-2,4,8-tetradecatrienamide|Lanyuamide II

C18H29NO2 (291.2198174)


   

Penbutolol

Penbutolol

C18H29NO2 (291.2198174)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Isobungeanool

2-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z,11E-tetraenamide

C18H29NO2 (291.2198174)


   

Bungeanool

2-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z,11Z-tetraenamide

C18H29NO2 (291.2198174)


   
   

2,4,6-Tri-tert-butylnitrobenzene

2,4,6-Tri-tert-butylnitrobenzene

C18H29NO2 (291.2198174)


   

Dodecanamide,N-(4-hydroxyphenyl)-

Dodecanamide,N-(4-hydroxyphenyl)-

C18H29NO2 (291.2198174)


   

4-methoxy-2,2,6,6-tetramethyl-1-(1-phenylethoxy)piperidine

4-methoxy-2,2,6,6-tetramethyl-1-(1-phenylethoxy)piperidine

C18H29NO2 (291.2198174)


   

(+)-Penbutolol

(+)-Penbutolol

C18H29NO2 (291.2198174)


(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2].

   
   

(4Z,7Z,10Z,13Z)-N-(2-hydroxyethyl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(2-hydroxyethyl)hexadeca-4,7,10,13-tetraenamide

C18H29NO2 (291.2198174)


   

(2e,4e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4 e,8z,11e)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide

NA

C18H29NO2 (291.2198174)


{"Ingredient_id": "HBIN005558","Ingredient_name": "(2e,4 e,8z,11e)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CCC=CCC=CCCC=CC=CC(=O)NCC(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10235","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2e,4 e,8z,11z)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide

NA

C18H29NO2 (291.2198174)


{"Ingredient_id": "HBIN005559","Ingredient_name": "(2e,4 e,8z,11z)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CCC=CCC=CCCC=CC=CC(=O)NCC(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5-hydroxy-2-methyl-6-(11'-oxododecyl)-pyridine

NA

C18H29NO2 (291.2198174)


{"Ingredient_id": "HBIN011591","Ingredient_name": "5-hydroxy-2-methyl-6-(11'-oxododecyl)-pyridine","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CC1=NC(=C(C=C1)O)CCCCCCCCCCC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10509","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

12-(3-hydroxy-6-methylpyridin-2-yl)dodecan-2-one

12-(3-hydroxy-6-methylpyridin-2-yl)dodecan-2-one

C18H29NO2 (291.2198174)


   

(2e,4e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z,10e,12r)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e,12r)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-ol

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-ol

C18H29NO2 (291.2198174)


   

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e,8z)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198174)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-ol

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-ol

C18H29NO2 (291.2198174)


   

(1r,2r,10s,11r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H29NO2 (291.2198174)


   

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H29NO2 (291.2198174)


   

(2e,4e,8z)-n-[(2s)-butan-2-yl]-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e,8z)-n-[(2s)-butan-2-yl]-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z,11z)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11z)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z,10e)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198174)


   

(2e,4e,8z,10e)-7-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e)-7-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198174)